Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Physics

Optics

Medicine

Pathology

Internal Medicine

Show all topics

DOI

10.1016/s0140-6736(08)60524-3